# Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy

> **NCT01538875** · PHASE3 · COMPLETED · sponsor: **Saint Thomas Hospital, Panama** · enrollment: 261 (actual)

## Conditions studied

- Hypertension, Pregnancy Induced

## Interventions

- **DRUG:** Hydralazine
- **DRUG:** Labetalol

## Key facts

- **NCT ID:** NCT01538875
- **Lead sponsor:** Saint Thomas Hospital, Panama
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-04
- **Final completion:** 2013-05
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2013-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01538875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01538875, "Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01538875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*